Stay abreast of COVID-19 information and developments here
Provided by the South African National Department of Health
BAT under fire,
but poised for growth
Head of Equities
Aug 25, 2017
BAT has been a star performer on the JSE over the last decade, beating the All Share Index (ALSI) return by 3% per year. Over this period, not only did the group deliver inflation-beating earnings growth, but the share re-rated from a forward price/earnings (P/E) multiple of 12 times in 2005 to 18 times in June 2017.
This rating change was in line with the global consumer staples sector, which benefited from the low interest-rate environment. The sector’s combination of predictable earnings growth and high dividends proved attractive as investors searched for yield.
On 28 July this year, the BAT share price declined by 7% as the US Food and Drug Administration (FDA) announced that it will look to reduce nicotine levels in cigarettes to ‘non-addictive levels’. This spooked the market, exacerbated by the recent completion of BAT’s deal to acquire the 52% of Reynolds American that it didn’t already own.
Investors should note that any FDA process will take a number of years as the regulations are only ‘proposed’ at this stage. The FDA also wants to reduce flavoured cigarettes, such as menthol, and push the use of non-combustible products (electronic cigarettes) as an alternative to traditional cigarettes.
The long time frame means there should be no impact on earnings for the next three to five years and investors can expect the same dividend growth as before.
So why then has the share price dropped? Potential new regulation decreases the visibility around longer-term earnings, which reduces what investors are willing to pay for the share, despite an unchanged medium-term earnings profile.
BAT’s management has, however, long been aware of the potential for increased regulation and will now look to engage the FDA on drafting sensible laws.
Should the new regulations come into effect as proposed and effectively reduce the addictiveness of cigarettes, BAT’s annual volume decline could deteriorate from 2022, which in turn reduces the group’s expected long-term growth rate.
BAT has a long history of successfully managing its cost base to reflect volume, mix and regulatory changes, and we expect this to continue as the group navigates future challenges.
The third part of the FDA’s proposal is to provide support for electronic cigarettes as an alternative. Reynolds American is the leader in this evolving industry and is thus best-placed to benefit. These next-generation products deliver higher margins and thus, irrespective of the FDA’s proposal, the group’s focus is to migrate customers from traditional cigarettes to next-generation products.
The tobacco industry will likely continue to consolidate, with leaders like BAT continuing to grow market share, while at the same time reinvesting cash flows to create dominance in the next-generation products. Expect the world’s largest cigarette companies to look substantially different a decade from now.
In the medium term, we remain comfortable with BAT’s ability to deliver 10% annual earnings and dividend growth in pounds. We believe the market has acted rationally given heightened longer-term uncertainty, but this should be resolved in due course. We believe BAT is fairly priced on a stand-alone basis, while offering attractive diversification for South African-based portfolios.
Sanlam Private Wealth manages a comprehensive range of multi-asset (balanced) and equity portfolios across different risk categories.
Our team of world-class professionals can design a personalised offshore investment strategy to help diversify your portfolio.
Our customised Shariah portfolios combine our investment expertise with the wisdom of an independent Shariah board comprising senior Ulama.
We collaborate with third-party providers to offer collective investments, private equity, hedge funds and structured products.
navigating the complexities
Sanlam Trustees International
are they a good investment?
The great lockdown:
one year on
Head of Equities
IHG: focus on
quality pays off
Sanlam Active UK Fund
BUDGET 2021: THE RIGHT INTENT,
BUT RISKS ABOUND
Investment Economist at Sanlam Investments
INVESTING IN 2021:
WHAT TO EXPECT
Sanlam Private Wealth
MINING: IS THE
THROUGH THE HYPE
Head of Equities
South AfricaSouth Africa Home Sanlam Investments Sanlam Private Wealth Glacier by Sanlam Sanlam BlueStar
Rest of AfricaSanlam Namibia Sanlam Mozambique Sanlam Tanzania Sanlam Uganda Sanlam Swaziland Sanlam Kenya Sanlam Zambia Sanlam Private Wealth Mauritius
GlobalGlobal Investment Solutions
Sanlam Private Wealth (Pty) Ltd, registration number 2000/023234/07, is a licensed Financial Services Provider (FSP 37473), a registered Credit Provider (NCRCP1867) and a member of the Johannesburg Stock Exchange (‘SPW’).
All reasonable steps have been taken to ensure that the information on this website is accurate. The information does not constitute financial advice as contemplated in terms of FAIS. Professional financial advice should always be sought before making an investment decision.
Participation in Sanlam Private Wealth Portfolios is a medium to long-term investment. The value of portfolios is subject to fluctuation and past performance is not a guide to future performance. Calculations are based on a lump sum investment with gross income reinvested on the ex-dividend date. The net of fee calculation assumes a 1.15% annual management charge and total trading costs of 1% (both inclusive of VAT) on the actual portfolio turnover. Actual investment performance will differ based on the fees applicable, the actual investment date and the date of reinvestment of income. A schedule of fees and maximum commissions is available upon request.
COLLECTIVE INVESTMENT SCHEMES
The Sanlam Group is a full member of the Association for Savings and Investment SA. Collective investment schemes are generally medium to long-term investments. Past performance is not a guide to future performance, and the value of investments / units / unit trusts may go down as well as up. A schedule of fees and charges and maximum commissions is available on request from the manager, Sanlam Collective Investments (RF) Pty Ltd, a registered and approved manager in collective investment schemes in securities (‘Manager’).
Collective investments are traded at ruling prices and can engage in borrowing and scrip lending. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. Collective investments are calculated on a net asset value basis, which is the total market value of all assets in a portfolio including any income accruals and less any deductible expenses such as audit fees, brokerage and service fees. Actual investment performance of a portfolio and an investor will differ depending on the initial fees applicable, the actual investment date, date of reinvestment of income and dividend withholding tax. Forward pricing is used.
The performance of portfolios depend on the underlying assets and variable market factors. Performance is based on NAV to NAV calculations with income reinvestments done on the ex-dividend date. Portfolios may invest in other unit trusts which levy their own fees and may result is a higher fee structure for Sanlam Private Wealth’s portfolios.
All portfolio options presented are approved collective investment schemes in terms of Collective Investment Schemes Control Act, No. 45 of 2002. Funds may from time to time invest in foreign countries and may have risks regarding liquidity, the repatriation of funds, political and macroeconomic situations, foreign exchange, tax, settlement, and the availability of information. The manager may close any portfolio to new investors in order to ensure efficient management according to applicable mandates.
The management of portfolios may be outsourced to financial services providers authorised in terms of FAIS.
TREATING CUSTOMERS FAIRLY (TCF)
As a business, Sanlam Private Wealth is committed to the principles of TCF, practicing a specific business philosophy that is based on client-centricity and treating customers fairly. Clients can be confident that TCF is central to what Sanlam Private Wealth does and can be reassured that Sanlam Private Wealth has a holistic wealth management product offering that is tailored to clients’ needs, and service that is of a professional standard.